Adverse Outcomes and Mortality in Liver Transplant

Description

Prospective natural history pilot study to explore the link between muscle composition using an MRI-based Muscle Assessment Score (MAsS) and adverse outcomes in liver transplant candidates.

Conditions

End Stage Liver DIsease, Sarcopenia, Sarcopenic Obesity, Cirrhosis

Talk to us

Study Overview

On this page

Study Details

Study overview

Prospective natural history pilot study to explore the link between muscle composition using an MRI-based Muscle Assessment Score (MAsS) and adverse outcomes in liver transplant candidates.

Adverse Outcomes and Mortality in Liver Transplant

Adverse Outcomes and Mortality in Liver Transplant

Condition
End Stage Liver DIsease
Intervention / Treatment

-

Contacts and Locations

Phoenix

Mayo Clinic Arizona, Phoenix, Arizona, United States, 85259

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. All patients with end-stage liver disease undergoing evaluation for liver transplantation
  • 2. Patient clinically indicated for MRI during transplant candidacy evaluation
  • 3. Adult
  • 1. Contra indication to MRI

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Mayo Clinic,

Elizabet Carey, MD, PRINCIPAL_INVESTIGATOR, Mayo Cinic

Study Record Dates

2026-07-01